AbClon앱클론
174900 · KOSDAQ · ₩174900 · 앱클론
Valuation model · Discounted cash flow (DCF)
We use a 5-year discounted cash flow: the value of the cash the business is expected to produce, in today's money.
Fair value per share
₩520
vs the current price (₩21,100)
- Enterprise value
- −₩19B
- Equity value
- ₩10B
- WACC
- 7.4%
Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal. This is not financial advice.
Why the model and the price differ
The model is 98% away from today's price. A gap this size usually means the market expects something the past figures don't show yet, or the model leaves something out. What we can see:
- No operating margin up to 90% gets the model to today's price at these growth assumptions.
- Margins ranged from −666.2% to −256.9% over the last 5 years, so this is a cyclical business. The model uses the average; the price may be set by where the cycle is now. Try the margin fade option.
- In the projection, spending on equipment, software and working capital takes most or all of the after-tax operating profit, so free cash flow is thin. Companies that invest heavily often look like this until spending slows.
Treat the model as a starting point: change the assumptions to the story you believe, and compare with the multiples check below.
Bear / Base / Bull
- Bear
- ₩694
- −96.7%
- Base
- ₩520
- −97.5%
- Bull
- ₩273
- −98.7%
Bear: revenue growth 3 points lower every year, EBIT margin 2 points lower, WACC 1 point higher. Bull: the opposite.
Assumptions
Sign in to change the assumptions and see the results update. Sign in
Cycle options
Margin path
Every year uses the cycle-average margin (−20.0%).
Revenue growth
- 11.4%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (11.4% a year, annual reports), fading to 3% by year 5.
- 9.3%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (11.4% a year, annual reports), fading to 3% by year 5.
- 7.2%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (11.4% a year, annual reports), fading to 3% by year 5.
- 5.1%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (11.4% a year, annual reports), fading to 3% by year 5.
- 3%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (11.4% a year, annual reports), fading to 3% by year 5.
Business
- -20%
Operating profit as a share of revenue.
Default: through-the-cycle average of the last 12 months and the last 5 annual reports' operating margins.
- 27.5%
Share of operating profit paid as corporate tax.
Default: Korea's top corporate tax rate (25%) plus 10% local income tax.
- 5.9%
The non-cash cost of wearing out equipment, added back to cash flow (% of revenue).
Default: not in the statements, so 80% of capital spending (most spending replaces equipment that wears out).
- 7.3%
Money spent on factories, equipment, software and other long-term assets (% of revenue).
Default: average of the last 3 annual reports (cash flow statements; equipment and intangibles).
- -10%
Stock and unpaid customer bills, less unpaid supplier bills, as a % of revenue. Each year's extra revenue ties up this much more cash.
Default: working capital (current assets less cash and deposits, minus current liabilities other than borrowings) as a share of revenue, averaged over the last 3 years.
Discount rate
- 2%
How fast cash flows keep growing every year after year 5.
Default: about Korea's long-run inflation plus real growth.
- 4.08%
Yield on Korea's 10-year government bond: the return with almost no risk.
Default: Korea Treasury Bond 10-year yield on 2026-10-29.
- 0.6
How much the share moves when the market moves: 1 means just like the market.
Default: 105 weeks of weekly returns against KOSPI (official index); raw beta 0.18, adjusted toward 1 and kept between 0.6 and 2.0.
- 5.5%
The extra return investors want for owning shares instead of bonds.
Default: a typical premium for Korean shares.
- 5.58%
The interest rate the company would pay to borrow.
Default: the 10-year yield plus a 1.5% credit spread.
Starting point
- Revenue (TTM to H1 2026)
- ₩5.3B
- Net debt (borrowings and leases − cash and deposits)
- −₩29B
- Shares
- 19,952,129
- Share price
- ₩21,100
- Market cap
- ₩421B
TTM = trailing 12 months: the last four reported quarters added together. "TTM to H1 2026" is the 12 months up to the latest quarterly or half-year report (H1 = to the end of June). Year 1 grows from there.
Past years and projection
Grey columns are reported results from the annual reports (after-tax EBIT at the model's tax rate), so you can check the growth and margin assumptions against the past. Years 1–5 are the model.
| FY2023 | FY2024 | FY2025 | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩2.9B | ₩2.3B | ₩4.7B | ₩5.9B | ₩6.5B | ₩6.9B | ₩7.3B | ₩7.5B |
| Growth | −15.5% | −18.7% | 101.5% | 11.4% | 9.3% | 7.2% | 5.1% | 3.0% |
| EBIT | −₩12B | −₩16B | −₩18B | −₩1.2B | −₩1.3B | −₩1.4B | −₩1.5B | −₩1.5B |
| EBIT margin | −404.8% | −666.2% | −374.1% | −20.0% | −20.0% | −20.0% | −20.0% | −20.0% |
| After-tax EBIT | −₩8.4B | −₩11B | −₩13B | −₩857M | −₩937M | −₩1B | −₩1.1B | −₩1.1B |
| + Depreciation | — | — | — | ₩349M | ₩381M | ₩409M | ₩430M | ₩442M |
| − Capital spending | ₩50M | ₩167M | ₩618M | ₩432M | ₩472M | ₩506M | ₩532M | ₩547M |
| − Working capital | −₩27B | ₩9.1B | −₩1.7B | −₩61M | −₩55M | −₩47M | −₩35M | −₩22M |
| Free cash flow | — | — | — | −₩880M | −₩973M | −₩1.1B | −₩1.1B | −₩1.2B |
| Discount factor | — | — | — | 0.931 | 0.867 | 0.808 | 0.752 | 0.700 |
| Present value | — | — | — | −₩819M | −₩843M | −₩852M | −₩844M | −₩820M |
Terminal value −₩21B, worth −₩15B today: 78% of enterprise value. It assumes spending settles at 110% of depreciation once growth slows to the terminal rate.
Cross-check: what the market has paid before
For cyclical businesses, analysts check a DCF against the multiples the stock has traded at through past cycles. Price / book is the usual anchor for them: P/E looks highest at the bottom of a cycle, when earnings are smallest, and lowest at the top. The price each band would give today:
| Low | Typical | High | |
|---|---|---|---|
| Price / book (book value ₩2,660 a share)Now 7.93× | ₩17,9406.74× | ₩31,60311.9× | ₩53,83520.2× |
Low, typical and high are the 10th percentile, middle and 90th percentile of month-end multiples since 2021, each against the latest report out by then, per share at today's share count; loss years and P/E above 100 are left out. Run-rate earnings are one quarter × 4, not a forecast. Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal.
Sensitivity
Fair value per share as two inputs change; the middle is the current case.
| WACC ↓ · Terminal growth → | 1.0% | 1.5% | 2.0% | 2.5% | 3.0% |
|---|---|---|---|---|---|
| 6.4% | ₩481 | ₩400 | ₩300 | ₩176 | ₩14 |
| 6.9% | ₩566 | ₩500 | ₩421 | ₩324 | ₩202 |
| 7.4% | ₩638 | ₩584 | ₩520 | ₩442 | ₩347 |
| 7.9% | ₩700 | ₩654 | ₩601 | ₩539 | ₩463 |
| 8.4% | ₩753 | ₩715 | ₩670 | ₩618 | ₩557 |
Now (TTM)
- Market cap
- ₩421B
- Enterprise value
- ₩392B
- P/E
- —
- P/B
- 7.9×
- P/S
- 79.3×
- EV/EBITDA
- —
- Dividend yield
- 0.0%
Over time (at each year end)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Price | ₩42,500 | ₩14,120 | ₩14,820 | ₩12,800 | ₩17,700 |
| Market cap | ₩848B | ₩282B | ₩296B | ₩255B | ₩353B |
| P/E | — | — | — | — | — |
| P/B | 14.0× | 9.6× | 10.9× | 7.0× | 18.2× |
| P/S | 179.9× | 120.4× | 102.8× | 75.0× | 117.0× |
| EV/EBITDA | — | — | — | — | — |
| Dividend yield | 0.0% | — | — | — | — |
Versus similar companies
| Company | P/E | P/B | P/S | EV/EBITDA | Dividend yield |
|---|---|---|---|---|---|
| AbClon | — | 7.9× | 79.3× | — | 0.0% |
| Samsung Biologics | 32.0× | 7.6× | 14.0× | — | 0.0% |
| Celltrion | 27.9× | 2.5× | 9.0× | — | 0.0% |
| Alteogen | 80.5× | 29.0× | 61.2× | — | 0.1% |
| SK biopharmaceuticals | 14.7× | 5.8× | 6.8× | — | 0.0% |
| Yuhan | 24.0× | 2.4× | 2.5× | 31.3× | 0.8% |
| HLB | — | 15.7× | 55.6× | — | 0.0% |
| Similar companies (median) | 27.9× | 6.7× | 11.5× | 31.3× | 0.0% |
Calculated from end-of-day prices and filed financial statements. Not a recommendation. This is not financial advice.
Also known as: AbClon / 앱클론 / 174900 / KRX:174900
Source: KRX statistical information